Nifty
Sensex
:
:
11930.35
40685.50
33.90 (0.28%)
127.01 (0.31%)

Pharmaceuticals & Drugs - API

Rating :
67/99  (View)

BSE: 524558 | NSE: NEULANDLAB

1201.95
9.75 (0.82%)
23-Oct-2020 | 3:51PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1200.00
  •  1223.00
  •  1192.25
  •  1192.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  42579
  •  511.78
  •  1312.15
  •  245.75

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,542.47
  • 60.10
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,755.08
  • 0.17%
  • 2.13

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 36.27%
  • 0.00%
  • 26.07%
  • FII
  • DII
  • Others
  • 20.79%
  • 4.19%
  • 12.68%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.75
  • 8.38
  • 13.08

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.99
  • 4.84
  • 15.10

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.85
  • -9.92
  • 10.36

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.38
  • 37.27
  • 40.53

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.74
  • 3.13
  • 2.06

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.09
  • 13.64
  • 14.06

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
205
181
13%
192
173
11%
204
171
19%
186
169
10%
Expenses
172
162
6%
162
154
5%
176
156
13%
161
154
5%
EBITDA
34
19
81%
30
18
63%
28
16
76%
25
15
69%
EBIDTM
16%
10%
14%
11%
14%
9%
13%
9%
Other Income
1
1
35%
2
1
34%
1
0
149%
1
1
-11%
Interest
5
4
33%
7
5
50%
6
3
90%
5
4
17%
Depreciation
9
8
17%
8
7
10%
8
7
6%
8
6
40%
PBT
20
8
167%
17
8
110%
16
6
161%
12
5
129%
Tax
5
2
172%
26
2
1620%
5
1
245%
4
1
319%
PAT
15
6
165%
-9
7
-
11
5
137%
9
5
91%
PATM
7%
3%
7%
4%
5%
3%
5%
3%
EPS
11.85
4.46
166%
-7.26
5.18
-
8.68
3.67
137%
6.79
3.55
91%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
787
763
667
527
579
510
469
466
461
448
397
Net Sales Growth
13%
14%
26%
-9%
14%
9%
1%
1%
3%
13%
 
Cost Of Goods Sold
4,940
380
366
238
263
253
244
247
269
285
250
Gross Profit
-4,153
383
301
289
316
257
225
219
191
164
147
GP Margin
-528%
50%
45%
55%
55%
50%
48%
47%
42%
37%
37%
Total Expenditure
670
661
608
477
473
430
403
395
403
402
350
Power & Fuel Cost
-
33
27
26
26
22
23
18
19
16
14
% Of Sales
-
4%
4%
5%
4%
4%
5%
4%
4%
4%
3%
Employee Cost
-
124
110
103
93
65
52
42
41
36
30
% Of Sales
-
16%
17%
20%
16%
13%
11%
9%
9%
8%
7%
Manufacturing Exp.
-
65
50
56
45
39
44
41
36
34
30
% Of Sales
-
8%
8%
11%
8%
8%
9%
9%
8%
8%
8%
General & Admin Exp.
-
28
27
33
28
30
24
16
16
14
14
% Of Sales
-
4%
4%
6%
5%
6%
5%
3%
4%
3%
4%
Selling & Distn. Exp.
-
18
18
14
11
18
15
27
14
11
11
% Of Sales
-
2%
3%
3%
2%
3%
3%
6%
3%
3%
3%
Miscellaneous Exp.
-
13
9
7
7
2
3
5
8
6
11
% Of Sales
-
2%
1%
1%
1%
0%
1%
1%
2%
1%
0%
EBITDA
117
102
58
50
106
80
67
71
58
47
47
EBITDA Margin
15%
13%
9%
10%
18%
16%
14%
15%
13%
10%
12%
Other Income
4
4
3
5
1
2
1
3
4
2
3
Interest
23
22
16
19
21
24
27
25
31
33
30
Depreciation
33
31
26
22
19
16
15
15
15
15
15
PBT
66
53
20
14
67
42
25
35
16
1
5
Tax
40
37
4
2
20
15
9
8
2
-2
0
Tax Rate
61%
69%
19%
13%
30%
36%
36%
23%
12%
-210%
-7%
PAT
26
16
16
12
47
27
16
27
14
3
5
PAT before Minority Interest
26
16
16
12
47
27
16
27
14
3
5
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
PAT Margin
3%
2%
2%
2%
8%
5%
3%
6%
3%
1%
1%
PAT Growth
19%
-1%
36%
-74%
71%
71%
-41%
93%
441%
-52%
 
EPS
20.05
12.66
12.84
9.42
36.61
21.35
12.45
20.94
10.83
2.00
4.13

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
710
699
558
546
187
161
124
100
76
74
Share Capital
13
13
9
9
9
9
8
8
5
5
Total Reserves
697
686
238
226
178
152
116
92
71
68
Non-Current Liabilities
163
104
146
54
69
55
52
62
59
74
Secured Loans
77
61
103
30
33
21
9
26
56
72
Unsecured Loans
0
0
0
0
12
12
25
25
0
0
Long Term Provisions
12
12
10
9
7
6
5
5
4
3
Current Liabilities
358
327
367
286
268
295
307
263
289
280
Trade Payables
116
120
124
86
84
112
94
82
111
104
Other Current Liabilities
72
57
42
47
55
31
64
40
40
38
Short Term Borrowings
168
149
199
151
124
146
140
133
132
134
Short Term Provisions
2
1
2
1
6
6
10
8
6
4
Total Liabilities
1,231
1,130
1,071
886
524
512
483
425
424
428
Net Block
623
512
445
436
139
123
131
136
151
158
Gross Block
714
575
483
455
292
264
259
250
254
246
Accumulated Depreciation
92
64
38
19
153
141
128
115
103
88
Non Current Assets
716
677
624
511
210
196
196
198
202
209
Capital Work in Progress
24
104
126
20
40
41
35
36
27
27
Non Current Investment
30
30
30
30
7
7
7
7
7
7
Long Term Loans & Adv.
36
31
23
25
23
24
23
11
6
5
Other Non Current Assets
3
0
0
0
0
0
0
8
11
11
Current Assets
515
453
447
375
314
316
288
227
222
219
Current Investments
8
8
8
8
0
0
0
0
0
0
Inventories
220
193
175
135
127
113
93
92
92
80
Sundry Debtors
190
164
194
181
119
129
119
98
96
100
Cash & Bank
47
38
17
12
10
7
7
1
3
5
Other Current Assets
51
20
16
14
59
67
68
35
30
34
Short Term Loans & Adv.
34
32
37
25
47
45
43
26
19
21
Net Current Assets
158
126
80
89
46
21
-19
-36
-67
-61
Total Assets
1,231
1,130
1,071
886
524
512
483
425
424
428

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
57
70
11
39
45
13
49
26
49
32
PBT
53
20
14
67
42
25
35
16
1
5
Adjustment
58
39
40
44
34
36
34
42
44
42
Changes in Working Capital
-49
15
-40
-56
-19
-39
-17
-31
5
-14
Cash after chg. in Working capital
62
75
14
55
57
22
52
27
50
33
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-5
-5
-3
-17
-12
-9
-3
-1
-1
0
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-49
-77
-116
-42
-20
-14
-10
-7
-5
-8
Net Fixed Assets
-58
-70
-135
-142
-27
-12
-7
-5
-8
-8
Net Investments
0
0
0
-30
0
0
0
0
0
0
Others
9
-7
19
130
7
-2
-3
-2
3
0
Cash from Financing Activity
-5
12
105
0
-24
1
-39
-20
-44
-24
Net Cash Inflow / Outflow
3
5
0
-4
1
0
0
-1
0
0
Opening Cash & Equivalents
8
3
3
7
1
1
1
2
2
2
Closing Cash & Equivalent
11
8
3
3
2
1
1
1
2
2

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
553
544
277
263
209
181
153
123
133
111
ROA
1%
1%
1%
7%
5%
3%
6%
3%
1%
1%
ROE
2%
3%
5%
22%
16%
11%
24%
16%
3%
8%
ROCE
8%
4%
4%
16%
19%
16%
19%
16%
11%
11%
Fixed Asset Turnover
1.18
1.26
1.13
1.57
1.86
1.82
1.87
1.86
1.82
1.67
Receivable days
85
98
129
93
87
95
83
76
79
78
Inventory Days
99
101
107
81
85
79
71
72
69
69
Payable days
65
76
82
67
85
93
82
88
98
91
Cash Conversion Cycle
118
123
154
107
87
81
73
59
50
56
Total Debt/Equity
0.37
0.33
1.30
0.82
0.98
1.17
1.55
2.13
2.93
3.23
Interest Cover
3
2
2
4
3
2
2
2
1
1

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.